Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation

• Status: Unknown status
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators hypothesize that reducing the duration of clopidogrel therapy from 6 months to 6 weeks after DES implantation is associated with improved clinical outcomes in patients on ASA and an oral anticoagulant.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Deutsches Herzzentrum Muenchen
• Treatments: Aspirin; Clopidogrel; Ticlopidine

Criteria

Key Inclusion Criteria:

1. Patients with an indication for oral anticoagulation and a DES implantation.

2. Informed, written consent by the patient or her/his legally-authorized representative for participation in the study.

Key Exclusion Criteria:

1. Age ≤18 years

2. Previous stent thrombosis

3. DES in left main